ROYAL BANK OF CANADA - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 109 filers reported holding VIKING THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$140,000
-42.4%
12,661
-15.5%
0.00%
Q2 2023$243,000
+1329.4%
14,980
+1395.0%
0.00%
Q1 2023$17,000
+183.3%
1,002
+67.0%
0.00%
Q4 2022$6,000
+500.0%
600
+89.9%
0.00%
Q3 2022$1,000316
+216.0%
0.00%
Q2 2022$0
-100.0%
100
-97.6%
0.00%
Q1 2022$13,000
-86.3%
4,203
-79.8%
0.00%
Q4 2021$95,000
-73.5%
20,769
-63.7%
0.00%
Q3 2021$359,000
+16.9%
57,168
+11.4%
0.00%
Q2 2021$307,000
-0.6%
51,334
+4.9%
0.00%
Q1 2021$309,000
+49.3%
48,942
+32.9%
0.00%
Q4 2020$207,000
-23.6%
36,824
-20.7%
0.00%
Q3 2020$271,000
-22.3%
46,428
-4.1%
0.00%
Q2 2020$349,000
+56.5%
48,436
+1.6%
0.00%
Q1 2020$223,000
-39.4%
47,655
+3.7%
0.00%
Q4 2019$368,000
+10.8%
45,962
-4.5%
0.00%
Q3 2019$332,000
-16.2%
48,129
+0.8%
0.00%
Q2 2019$396,000
-23.6%
47,762
-8.3%
0.00%
Q1 2019$518,000
+90.4%
52,064
+46.4%
0.00%
Q4 2018$272,000
+192.5%
35,570
+569.7%
0.00%
Q3 2018$93,000
+220.7%
5,311
+70.2%
0.00%
Q2 2018$29,000
+81.2%
3,120
-13.4%
0.00%
Q1 2018$16,000
+33.3%
3,601
+20.0%
0.00%
Q4 2017$12,0003,001
+300000.0%
0.00%
Q3 2017$0
-100.0%
1
-100.0%
0.00%
Q4 2015$18,0003,1250.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders